Dr. Taofeek Owonikoko is a Professor and Vice Chair for Faculty Development in the Department of Hematology and Medical Oncology at Emory University, Atlanta. He is also a Georgia Research Alliance Distinguished Cancer Scientist. Owonikoko received his medical degree from the Obafemi Awolowo University, Ile-Ife Nigeria in 1991 and a doctoral degree in Anatomic Pathology from the Heinrich Heine University, Dusseldorf, Germany in 2000. He has been on faculty at Emory University since 2008 and has focused on lung cancer, thyroid cancer as well as early phase drug development.
Flere episoder fra "The Moss Report"
“Can Homeopathy Fight Cancer?” with Dana Ullman, MPH
36:50In this episode of The Moss Report Podcast, Dr. Ralph Moss speaks with Dana Ullman, MPH, CCH, about the role of homeopathy in cancer treatment. Moss and Ullman discuss an important journal article, which appeared in “The Oncologist” (whose editor-in-chief is a prominent oncologist, Bruce Chabner, MD). This article concluded that personalized homeopathic treatment added to conventional therapy could improve the quality of life and extend the survival of people with lung cancer. Dana Ullman, MPH, CCH is considered one of the world’s leading advocates for homeopathy and speaks with Moss about the importance of integrative care that includes the use of micro-doses of various substances. For more information, see www.homeopathic.com or https://homeopathicfamilymedicine.com/
Rache Simmons on Cryoablation for Breast Cancer!
50:35Rache Simmons, MD, is a distinguished surgeon at Weill-Cornell Medical School. She is a graduate of Duke University and Duke University Medical School. In this episode, Simmons discusses her approach to provide minimally invasive and cosmetically superior breast surgical care using cryoablation and explains how the close communication among the physicians and health professionals involved in the care of each patient is fundamental to achieving excellent outcomes and the highest quality of life after treatment.
Gå ikke glip af nogen episoder af “The Moss Report” - abonnér på podcasten med gratisapp GetPodcast.
Vitamin D and Cancer with William B. Grant, PhD
42:23In this episode, Dr. Ralph Moss talks with William Grant, PhD, one of the leading experts on vitamin D and cancer. Grant is the founding director of Sunlight, Nutrition, and Health Research Center (SUNARC) of San Francisco. He has a doctorate in physics from the University of California at Berkeley. Dr. Grant is the author of ~300 PubMed-listed articles on vitamins, 163 of which concern the relationship of vitamin D to cancer.
Natural Compounds for a Suppression-Centric Anticancer Strategy
48:07Myfanwy J. Webb, Ph.D is a Conjoint Fellow in the School of Medicine and Public Health College of Health, Medicine and Wellbeing at the University of Newcastle, Australia. After being diagnosed with the highly aggressive, triple-negative breast cancer (TNBC), Webb began a quest to find the nutritional factors that could counteract this disease. She focused on the all-important cancer stem cells (CSCs) and devised a program of nutritional supplements that were most likely to suppress those stem cells. For more information, see www.TargetCancerNaturally.com
Patient Navigation with Elisabeth Schuler
39:19In this episode, Rachael Moss talks with patient advocate Elisabeth Schuler about how to make the most of your visits, how to go in feeling prepared, and how to manage the logistics of a diagnosis without feeling like you’re in over your head. Patient advocates can be a loved one, or a hired professional who helps sort through a diagnosis, looks into treatment options, points toward resources, spends time talking with healthcare companies, and is available for the questions that brief doctor’s visits may not answer.
Patrick Quillin, PhD, RD, CNS on Diet and Nutrition
42:33Patrick Quillin, PhD, RD, CNS, is a well-known expert in the area of nutrition and cancer. He has 40 years experience as a clinical nutritionist, of which 10 years were spent as the Vice President of Nutrition for Cancer Treatment Centers of America (CTCA), where he worked with thousands of cancer patients in multiple hospital settings. According to Quillin, cancer has escalated from a once obscure disease to a leading cause of death worldwide. Chemotherapy, radiation, and surgery may reduce tumor burden but do not change the underlying causes of the disease.
Taofeek Owonikoko, MD, PhD on Lung and Thyroid Cancers and Early Phase Drug Development
53:36Dr. Taofeek Owonikoko is a Professor and Vice Chair for Faculty Development in the Department of Hematology and Medical Oncology at Emory University, Atlanta. He is also a Georgia Research Alliance Distinguished Cancer Scientist. Owonikoko received his medical degree from the Obafemi Awolowo University, Ile-Ife Nigeria in 1991 and a doctoral degree in Anatomic Pathology from the Heinrich Heine University, Dusseldorf, Germany in 2000. He has been on faculty at Emory University since 2008 and has focused on lung cancer, thyroid cancer as well as early phase drug development.
Dan Rubin, ND on Naturopathic Oncology
58:52Dan Rubin, ND, of Scottsdale, Arizona, is one of the leading naturopathic physicians in the United States. His naturopathic oncology practice has been an integral part of the Phoenix metropolitan medical community for the past 20 years. A graduate of the Southwest College of Naturopathic Medicine (SCNM) in 1997, Rubin founded the Oncology Association of Naturopathic Physicians (OncANP). The OncANP represented a revolution for the field of naturopathic oncology providing, for the first time, definition, validation, and standardization of the field of naturopathic oncology. Since that time Rubin has been an internationally recognized naturopathic oncologist.
Stress and the Cancer Mindset with Author, Brandon LaGreca
38:58In this episode, Rachael Moss speaks with Brandon LaGreca LAc, MAcOM about the importance of mindset when it comes to cancer. Brandon LaGreca is a licensed acupuncturist in Wisconsin who is nationally certified in Oriental medicine. In 2015, he was diagnosed with stage 4 non-Hodgkin lymphoma (NHL). Eight months later, he had a complete remission following an integrative medicine protocol that included immunotherapy. This was achieved without the use of chemotherapy, radiation, or surgery. LaGreca also shares his thoughts at www.EmpoweredPatientBlog.com.